← Evidence map

ArticleMovement disorders : official journal of the Movement Disorder Society2020

Precision Medicine for Parkinson's Disease: Ambroxol for Glucocerebrosidase-Associated Parkinson's Disease, First Trial Completed.

Susanne A Schneider et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32379375